- Home
- TMUS vs NVO Comparison
TMUS vs NVO Comparison
Compare TMUS & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMUS
- NVO
- Stock Information
- Founded
- TMUS 1994
- NVO 1923
- Country
- TMUS United States
- NVO Denmark
- Employees
- TMUS N/A
- NVO N/A
- Industry
- TMUS Telecommunications Equipment
- NVO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TMUS Telecommunications
- NVO Health Care
- Exchange
- TMUS Nasdaq
- NVO Nasdaq
- Market Cap
- TMUS 248.6B
- NVO 278.0B
- IPO Year
- TMUS N/A
- NVO N/A
- Fundamental
- Price
- TMUS $243.81
- NVO $65.73
- Analyst Decision
- TMUS Buy
- NVO Strong Buy
- Analyst Count
- TMUS 20
- NVO 4
- Target Price
- TMUS $252.87
- NVO $128.00
- AVG Volume (30 Days)
- TMUS 4.2M
- NVO 11.2M
- Earning Date
- TMUS 04-24-2025
- NVO 05-07-2025
- Dividend Yield
- TMUS 1.44%
- NVO 2.45%
- EPS Growth
- TMUS 39.35
- NVO 17.93
- EPS
- TMUS 10.25
- NVO 3.40
- Revenue
- TMUS $82,692,000,000.00
- NVO $43,922,211,349.00
- Revenue This Year
- TMUS $7.27
- NVO $20.22
- Revenue Next Year
- TMUS $5.17
- NVO $16.10
- P/E Ratio
- TMUS $23.93
- NVO $19.32
- Revenue Growth
- TMUS 5.31
- NVO 24.11
- 52 Week Low
- TMUS $161.72
- NVO $57.00
- 52 Week High
- TMUS $276.49
- NVO $148.15
- Technical
- Relative Strength Index (RSI)
- TMUS 43.02
- NVO 48.22
- Support Level
- TMUS $230.64
- NVO $64.40
- Resistance Level
- TMUS $254.16
- NVO $69.67
- Average True Range (ATR)
- TMUS 6.06
- NVO 1.74
- MACD
- TMUS -0.13
- NVO 0.85
- Stochastic Oscillator
- TMUS 39.73
- NVO 62.20
About TMUS T-Mobile US Inc.
Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, and that firm merged with Sprint in 2020, creating the second-largest wireless carrier in the us. T-Mobile now serves 77 million postpaid and 21 million prepaid phone customers, equal to around 30% of the us retail wireless market. The firm entered the fixed-wireless broadband market aggressively in 2021 and now serves more than 5 million residential and business customers. In addition, T-Mobile provides wholesale services to resellers.
About NVO Novo Nordisk A/S
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.